Rathbones Group Plc Reports on Life Science REIT Holdings

Author: Kelly Martin Updated: 07-01-2025 09:00 AM

Rathbones Group Plc's Disclosure on Life Science REIT Holdings

In line with regulatory requirements, Rathbones Group Plc provides a comprehensive disclosure on their stake in Life Science REIT Plc. This disclosure is crucial for maintaining transparency in the market.

Key Information About the Disclosure

The disclosure outlines essential information whereby Rathbones Group Plc acknowledges its significant position in Life Science REIT Plc. This entails a detailed account of their ownership and trading activities concerning the company's securities.

Identity of Discloser

The full name of the entity making this disclosure is Rathbones Group Plc. As a major institutional investor, the group holds significant interests in various securities within the financial market.

Relevant Securities

In regards to interests in relevant securities, Rathbones Group Plc confirms ownership of a notable number of 1p Ordinary Shares in Life Science REIT Plc. The current holdings amount to approximately 49,879,809 shares. This represents about 14.25% of the total shares issued by Life Science REIT Plc.

Positions of Rathbones Group Plc in Life Science REIT Plc

Following recent dealings, Rathbones Group Plc's interests in Life Science REIT Plc remain a focal point for market observers. The company's stake showcases its commitment to the life sciences sector.

Details of Securities Held

As of the latest reporting date, Rathbones Group Plc has not disclosed any new positions or short interests beyond what is noted in public disclosures. The type of securities held includes only ordinary shares without any involvement in derivatives or other financial instruments related to Life Science REIT Plc.

Trading Activities and Transactions

Recent transactions by Rathbones Group Plc include various market dealings, highlighting their proactive management of investment positions. Notably, the firm executed multiple sales of shares within the reporting period.

Detailed Trading Information

Under the stipulated rules, Rathbones Group Plc has conducted sales of 12,600 shares at a price of 46.7515p and 41,000 shares at 46.66p, reflecting strategic decisions to manage their portfolio effectively. This trading activity emphasizes the responsiveness to market conditions and opportunities.

Future Commitments

No new options or derivative transactions have been registered, ensuring a clear and comprehensive understanding of their current and future commitments in relation to Life Science REIT Plc.

Regulatory Compliance and Contact Information

Rathbones Group Plc ensures all disclosures comply with regulatory standards set forth in the Takeover Code. This commitment is underscored by proactive engagement with stakeholder communications and adherence to public disclosure requirements.

Contact Details

For further inquiries, stakeholders are encouraged to reach out to Chinwe Enyi from the Compliance Department at Rathbones Group Plc. The contact number for inquiries is 0151 243 7053.

Frequently Asked Questions

What is the purpose of this disclosure?

The disclosure aims to provide transparency regarding Rathbones Group Plc's significant holdings and trading activities in Life Science REIT Plc.

How many shares does Rathbones Group Plc hold?

Rathbones Group Plc holds 49,879,809 shares, which is approximately 14.25% of the total issued shares of Life Science REIT Plc.

What types of transactions were reported?

The transactions included sales of ordinary shares at prevailing market prices.

Who can I contact for more information?

For inquiries, you may contact Chinwe Enyi of the Compliance Department at 0151 243 7053.

Is any other party being disclosed?

No, the disclosure is exclusive to Rathbones Group Plc's position in Life Science REIT Plc.

About The Author

Hello Kelly Martin here, a financial and publicly traded company specialist committed to writing with clarity and sage advice. Having a wealth of experience and a thorough grasp of corporate dynamics and the financial environment, my main goal in writing blog posts and articles is to provide insightful analysis together with useful guidance. My objective is to arm readers with the information they need to comprehend the complexities of publicly traded companies and make wise financial decisions.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors to seasoned pros looking for fresh perspectives. My goal is to make corporate analysis and finance understandable and interesting so you may confidently negotiate the intricacies of the financial world. I appreciate you traveling with me toward success and financial literacy.

Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.